Fig. 2.

Molecular targets for cannabidiol (CBD) in Alzheimer's disease (AD). Cannabinoid receptors (CB1/CB2), transient receptor potential cation channel subfamily V member 1 (TRPV1), Wnt/GSK-3β (Wnt/glycogen synthase kinase 3 beta pathway), amyloid precursor protein (APP), beta-amyloid (Aβ) peptide, peroxisome proliferator-activated receptors (PPARγ), beta-catenin (β-catenin), neurofibrillary tangles (NFTs), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), tau protein (TAU), reactive oxygen species (ROS).